Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

(2010) Francesco Rodeghiero   EUROPEAN JOURNAL OF HAEMATOLOGY

Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy

(2010) Maria Gabriella Mazzucconi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases

(2010) P. Fenaux et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The ITP syndrome: pathogenic and clinical diversity

(2009) D. B. Cines et al.   BLOOD

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD